Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 4

Clinical characteristics and long-term outcome of Takayasu arteritis in Iran: a multicentre study

Pages
713–724
Publication Date
2020-08-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The issue of delay in diagnosis should create awareness among health care providers that TA is not a very rare disease in Iranians and failure to pay attention to warning symptoms may delay the diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: This study aimed to evaluate the demographic, clinical, angiographic and prognostic characteristics of Takayasu arteritis TA in Iran.
📊
Key Findings & Data:Materials and methods: A total of 75 patients with TA based on the American College of Rheumatology 1990 criteria for TA classification referred to the Rheumatology Centres, were followed-up from 1989 to 2019.
💡
Conclusion & Impact:The issue of delay in diagnosis should create awareness among health care providers that TA is not a very rare disease in Iranians and failure to pay attention to warning symptoms may delay the diagnosis.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Takayasu arteritis · Birmingham Vasculitis Activity Score BVAS · Indian Takayasu Clinical Activity Score ITAS

Abstract

Background/aim: This study aimed to evaluate the demographic, clinical, angiographic and prognostic characteristics of Takayasu arteritis TA in Iran. Materials and methods: A total of 75 patients with TA based on the American College of Rheumatology 1990 criteria for TA classification referred to the Rheumatology Centres, were followed-up from 1989 to 2019. Demographic, clinical, angiographic and prognostic characteristics were collected at baseline and last visit. Results: The mean age was 31.9 ± 9.8 years at the disease onset. Female to male ratio was 14. The median latency in diagnosis was 24 months. Pulse discrepancy in the arms, blood pressure discrepancy in the arms, limb claudication, hypertension and constitutional symptoms were the most common clinical features. The most common angiographic type at the time of diagnosis was Type I 42.7% . The most frequent arterial lesion was stenosis 89.4% . Subclavian, carotid and aortic arteries were the most commonly involved arteries. New lesions developed in 28.6% of patients during the 5.25-year follow-up. Vasculitis-induced chronic damage was observed in all patients. Disease activity decreased and vascular damage remained stable throughout the follow-up period. Conclusions: The clinical features and angiographic type of TA in Iran are different from most Asian countries. Differences in angiographic and clinical features may lead to delayed diagnosis. The issue of delay in diagnosis should create awareness among health care providers that TA is not a very rare disease in Iranians and failure to pay attention to warning symptoms may delay the diagnosis.

🔖

Cite This Article

MAHDAVI, A. M., RASHTCHIZADEH, N., KAVANDI, H., HAJIALILO, M., KOLAHI, S., NAKHJAVANI, M., EBRAHIMI, A., SEYEDMARDANI, S., SALESI, M., SOROUSH, M., KHABBAZI, A. (2020). Clinical characteristics and long-term outcome of Takayasu arteritis in Iran: a multicentre study. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 4, 713–724. https://ajindex.com/articles/113165

References (12)

  1. Seyahi E. Takayasu arteritis: an update. Current Opinion in Rheumatology 2017
  2. 29 (1): 51-56. doi: 10.1097/ BOR.0000000000000343 2. Onen F, Akkoc N. Epidemiology of Takayasu arteritis. La Presse Médicale 2017
  3. 46 (7-8 Pt 2): 197-203. doi: 10.1016/j. lpm.2017.05.034 3. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis and Rheumatism 1990
  4. 33 (8): 1129-1134. doi: 10.1002/art.1780330811 4. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. International Journal of Cardiology 1996
  5. 54 (Suppl): 155-163. doi: 10.1016/ s0167-5273(96)02813-6 5. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS et al. Takayasu arteritis. Annals of Internal Medicine 1994
  6. 120 (11): 919-929. doi: 10.7326/0003-4819-120-11-199406010-00004 6. Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Annals of the Rheumatic Disease 2009
  7. 68 (12): 1827-1832. doi: 10.1136/ard.2008.101279 7. Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford, England)) 2013
  8. 52 (10): 1795-1801. doi: 10.1093/ rheumatology/ket128 8. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis and Rheumatism 1997
  9. 40 (2): 371-380. doi: 10.1002/art.1780400222 9. Flossmann O, Bacon P, de Groot K, Jayne D, Rasmussen N, et al. Development of comprehensive disease assessment in systemic vasculitis. Annals of the Rheumatic Diseases 2007
  10. 66 (3): 283-292. doi: 10.1136/ard.2005.051078 10. Park MC, Lee SW, Park YB, Chung NS. Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scandinavian Journal of Rheumatology 2005
  11. 34 (4): 284-292. doi: 10.1080/03009740510026526 11. Yang L, Zhang H, Jiang X, Zou Y, Qin F, Song L, et al. Clinical Manifestations and Long-term Outcome for Patients with Takayasu Arteritis in China. The Journal of Rheumatology 2014
  12. 41 (12): 2439-2446. doi: https://doi.org/10.3899/ jrheum.140664 12. Jing Li, Fei Sun, Zhe Chen, Yang Y, Zhao J et